Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 9/20 | 0.71 |
| ▸ | CACNA1D | Q01668 | 9/20 | 0.71 |
| ▸ | CACNA1S | Q13698 | 9/20 | 0.71 |
| ▸ | CACNA1C | Q13936 | 9/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.71 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.68 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.65 |
| ▸ | THPO | P40225 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3032197 | 1.00 | CACNA1F (0.71) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| Hydrochloric Acid SCHEMBL9805019 | 0.99 | CACNA1F (0.70) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| Hydrochloric Acid SCHEMBL9374052 | 0.99 | CACNA1F (0.70) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| Hydrochloric Acid SCHEMBL9374064 | 0.99 | CACNA1F (0.70) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| Hydrochloric Acid SCHEMBL9805027 | 0.99 | CACNA1F (0.70) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| Oxalic Acid SCHEMBL9725491 | 0.97 | CACNA1F (0.68) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| SCHEMBL8883552 | 0.95 | CACNA1F (0.65) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| SCHEMBL30296731 | 0.95 | CACNA1F (0.65) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| SCHEMBL15463931 | 0.94 | CACNA1F (0.64) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| SCHEMBL15464038 | 0.94 | CACNA1F (0.64) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2703398-A1 | 1,4-DIHYDROPYRIDINE -3,5-DICARBOXYLATE DERIVATIVES, PREPARATION METHODS AND USES THEREOF | Xuanzhu Pharma Co., Ltd. (CN) | 2014-03-05 | — | — | EP | claimed |
| EP-1179345-B1 | INHIBITORS AGAINST INCREASE IN OCULAR TENSION CAUSED BY IRRADIATION WITH LASERS, CONTAINING 1,4-DIHYDROPYRIDINE DERIVATIVES | SENJU PHARMA CO (JP) | 2009-04-08 | — | — | EP | claimed |
| EP-0968716-B1 | DRUGS FOR AMELIORATING OCULAR CIRCULATORY DISORDERS | SENJU PHARMA CO (JP) | 2008-12-31 | — | — | EP | claimed |
| EP-1860102-B1 | Process for Producing Lercanidipine | CF PHARMA LTD (HU) | 2008-11-26 | — | — | EP | claimed |
| EP-0824517-B1 | A PROCESS FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE | RECORDATI CHEM PHARM (IT) | 2002-07-24 | — | — | EP | claimed |
| EP-0463407-B1 | Use of dihydropyridins in cardiotonic pharmaceutical compositions | MITSUBISHI PHARMA CORP (JP) | 2002-02-13 | — | — | EP | claimed |
| EP-0342577-B1 | Use of dihydropyridine derivatives for the prophylaxis or treatment of cerebral circulation disorders | YOSHITOMI PHARMACEUTICAL (JP) | 2000-03-15 | — | — | EP | claimed |
| EP-0289746-B1 | 1,4-Dihydropyridine derivatives and pharmaceutical composition thereof | KYOTO PHARMA IND (JP) | 1994-10-19 | — | — | EP | claimed |
| EP-0176956-B1 | Diaryl derivatives | BYK GULDEN LOMBERG CHEM FAB (DE) | 1994-06-15 | — | — | EP | claimed |
| EP-0063365-B2 | 1,4-Dihydropyridine derivative and pharmaceutical composition containing same | KYOWA HAKKO KOGYO KK (JP) | 1994-06-15 | — | — | EP | claimed |
| EP-0220917-B1 | 1,4-DIHYDROPYRIDINE PHARMACEUTICAL DERIVATIVES AND THEIR SALTS, AND THE PREPARATION THEREOF | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1991-01-30 | — | — | EP | claimed |
| EP-0094159-B1 | DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1990-03-14 | — | — | EP | claimed |
| EP-0194906-B1 | HETEROCYCLIC DISSYMMETRIC 1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC-ACID ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL USE | FOURNIER INNOVATION ET SYNERGIE (FR) | 1989-07-19 | — | — | EP | claimed |
| US-4798840-A | Coronary-active fluorine-containing 1,4-dihydropyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1989-01-17 | — | — | US | claimed |
| US-4713387-A | Vasodilating and platelet aggregation inhibiting 1,4 dihydropyridines with an imidazolyl or pyridyl containing ester | TOYAMA CHEMICAL CO., LTD. (JP) | 1987-12-15 | — | — | US | claimed |
| EP-0240398-A1 | Dissymmetrical 1,4-dihydropyridine-3,5-dicarboxylic-acid derivatives, preparation processes and therapeutical use | FOURNIER INNOVATION ET SYNERGIE (FR) | 1987-10-07 | — | — | EP | claimed |
| EP-0194906-A2 | Heterocyclic dissymmetric 1,4-dihydropyridine-3,5-dicarboxylic-acid esters, process for their preparation and their therapeutical use | FOURNIER INNOVATION ET SYNERGIE (FR) | 1986-09-17 | — | — | EP | claimed |
| EP-0063365-B1 | 1,4-DIHYDROPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-09-04 | — | — | EP | claimed |
| EP-0126094-A1 | NEW 1,4-DIHYDROPYRIDINE ESTERS AND PREPARATION METHODS THEREOF AND DRUGS CONTAINING SAID ESTERS. | CERMOL SA (CH) | 1984-11-28 | — | — | EP | claimed |
| WO-1984002132-A1 | NEW 1,4-DIHYDROPYRIDINE ESTERS AND PREPARATION METHODS THEREOF AND DRUGS CONTAINING SAID ESTERS | CERMOL SA (CH) | 1984-06-07 | — | — | WO | claimed |